Sharad Verma

Assistant Professor

19972018
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1997 2018

Filter
Letter
2012

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

McCabe, M. T., Ott, H. M., Ganji, G., Korenchuk, S., Thompson, C., Van Aller, G. S., Liu, Y., Pietra, A. D., LaFrance, L. V., Mellinger, M., Duquenne, C., Tian, X., Kruger, R. G., McHugh, C. F., Miller, W. H., Dhanak, D., Verma, S., Tummino, P. J., Creasy, C. L., Graves, A. P. & 1 others, Diaz, E., Dec 6 2012, In : Nature. 492, 7427, p. 108-112 5 p.

Research output: Contribution to journalLetter

Lymphoma, Large B-Cell, Diffuse
Lymphoma
Polycomb Repressive Complex 2
Mutation
Follicular Lymphoma